Beyond pressure injuries: the prognostic potential of the Braden scale in elderly heart failure patients in intensive care unit—a commentary
Year: 2025
Type: article
Abstract: This invited commentary refers to ‘The prognostic value of the Braden scale on all-cause death in older patients with heart failure in the intensive care unit: a cohort study’, by J. Zhu et al., https://doi.org/10.1093/eurjcn/zvaf133. Pressure injuries (PIs) are defined as localized damage to the skin and/or underlying tissue resulting from prolonged pressure or the combination of pressure and shear forces, typically occurring over bony prominences or in association with medical or other devices.1 Intensive care patients are considered high-risk groups for developing PIs due to risk factors such as older age, limited mobility or activity, impaired perfusion, vasopressor use, and longer intensive care unit (ICU) length of stay.2 Supporting the clinical assessment obtained immediately after a detailed skin examination upon admission to intensive care with a valid, reliable risk assessment tool is a key intervention in maintaining skin integrity and preventing PIs.1,3 The Braden scale is one of the most commonly used risk assessment tools in ICUs internationally, providing assessments across the dimensions of sensory perception, activity, mobility, moisture, friction-shear, and nutrition. However, the Braden scale does not include any physiological or laboratory findings, and the assessment is based on the primary nurse’s clinical judgment. For this reason, it is crucial to evaluate the specificity, accuracy, and consistency of scale assessments as well as to determine the associated clinical conditions in different populations. The large-scale cohort study conducted by Zhu et al.4 is noteworthy in that it investigates whether the Braden scale has value beyond predicting the risk of PIs. In this study, the Braden scores of 13 127 heart failure (HF) patients aged 60 years and older were retrospectively analysed during their ICU admission. The findings demonstrated that 30-day all-cause mortality rates were significantly higher in the moderate-to-high-risk group (BSS ≤ 15) compared with the low-risk group (P < 0.001). Furthermore, survival analyses revealed that 30-, 90-, and 180-day survival outcomes were also significantly worse in the moderate-to-high-risk group. Heart failure is a critical clinical condition characterized by a reduced ejection fraction and high mortality, and it also causes impaired peripheral tissue perfusion.5 The nature of HF, with its reduced tissue perfusion, combined with the use of vasopressor drugs in ICUs and reduced mobilization, has a detrimental effect on skin health, along with factors such as the patient’s critical and unstable vital signs. Consequently, it exerts a direct influence on the pathophysiology of PIs, encompassing ischaemia, reperfusion injury, tissue damage, and diminished lymphatic drainage processes.6 Peripheral oedema, which develops in advanced stages of HF or during periods when symptoms worsen or medical treatment is ineffective, is also an additional risk factor for skin integrity.7,8 Oedema, frequently observed in the lower extremities, also occurs in the sacral region with increased bedridden status in the ICU, making this anatomical area more vulnerable to PIs.9 Consequently, the likelihood of PI developing is significantly increased in ICU patients with HF. The deterioration in tissue perfusion that develops due to the heart’s reduced pumping function creates a suitable environment for PIs. Although the Braden scale has long been used to predict the risk of PIs, studies investigating its relationship with broader clinical outcomes, such as mortality, are limited. In this context, the study by Zhu et al. fills an important gap in the literature. The findings demonstrate that the Braden scale, used by nurses in their daily practice, can also provide predictions regarding patient mortality. They support the multifaceted use of the Braden scale and suggest that it should be considered as a predictor for early awareness of increasing mortality. This finding highlights the prognostic potential of nursing care. One of the most important aspects of the study in terms of its clinical application is that the Braden scale is simple, practical, and cost-effective. These characteristics enable it to be easily integrated into risk triage processes in ICUs. For example, knowing that patients with low Braden scores, i.e. those at moderate/high risk of PIs, should be closely monitored not only for PIs but also for mortality risk may enable nurses and the interdisciplinary team to reprioritize care, enhance the frequency of mortality risk monitoring, and accelerate the initiation of advanced interventions. However, it is imperative to acknowledge the limitations of the present study. The single-centre, retrospective design may limit the generalizability of the results. The Braden score was assessed only at admission, which precludes evaluation of dynamic changes over the ICU stay. It is recommended that this significant finding, derived from retrospective data, be substantiated by prospective, single-, and multicentre studies. Furthermore, future studies should be planned to investigate the contribution of changes in the Braden score over time to mortality prediction. In conclusion, Zhu et al. demonstrated that the Braden scale, beyond its traditional role in predicting PI risk, may also serve as a useful predictor of mortality in older ICU patients with HF. This finding highlights the broader prognostic potential of nursing tools and emphasizes the importance of integrating routine nursing assessments into patient outcome prediction. By bridging nursing assessment with prognostic outcomes, this study underscores the evolving role of nursing instruments in advancing patient-centred and holistic intensive care practice. The utilization of prospective studies to validate this significant finding will reinforce the multifaceted application of the Braden scale. Furthermore, it will contribute to the enhancement of nursing care in intensive care, ensuring that it becomes patient-centred, holistic, and predictive. Tugba Erdem (Conceptualization [lead], Writing—original draft [lead], Writing—review & editing [lead]) This commentary did not receive any funding. This commentary does not contain new data.
Author: Tugba Erdem
Institution: Koç University
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4414414753
